Implementation of second-tier tests in newborn screening for the detection of vitamin B

Homocysteine Homocystinuria Methylcitric acid Methylmalonic acid Methylmalonic acidemia Newborn screening Propionic acidemia Second-tier test Vitamin B12 deficiency

Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 12 01 2021
accepted: 16 03 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 29 6 2021
Statut: epublish

Résumé

Alteration of vitamin B A screening strategy using the usual primary markers followed by the analysis of MMA, MCA and Hcys as second tier-test in the first dried blood spot (DBS) was developed and evaluated. During the period 2015-2018 a total of 258,637 newborns were screened resulting in 130 newborns with acquired vitamin B When screening for methylmalonic acidemia and homocystinuria, differential diagnosis with acquired vitamin B

Sections du résumé

BACKGROUND
Alteration of vitamin B
METHODS
A screening strategy using the usual primary markers followed by the analysis of MMA, MCA and Hcys as second tier-test in the first dried blood spot (DBS) was developed and evaluated.
RESULTS
During the period 2015-2018 a total of 258,637 newborns were screened resulting in 130 newborns with acquired vitamin B
CONCLUSIONS
When screening for methylmalonic acidemia and homocystinuria, differential diagnosis with acquired vitamin B

Identifiants

pubmed: 33931066
doi: 10.1186/s13023-021-01784-7
pii: 10.1186/s13023-021-01784-7
pmc: PMC8086297
doi:

Substances chimiques

Vitamins 0
Homocysteine 0LVT1QZ0BA
Methylmalonic Acid 8LL8S712J7
Vitamin B 12 P6YC3EG204

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

195

Commentaires et corrections

Type : ErratumIn

Références

J Pediatr Hematol Oncol. 2004 Apr;26(4):270-1
pubmed: 15087959
J Pediatr. 2020 Jan;216:165-172.e4
pubmed: 31604629
Mol Genet Metab Rep. 2018 Jan 11;15:1-5
pubmed: 29387561
J Child Neurol. 2015 Apr;30(5):641-3
pubmed: 24453156
Eur J Pediatr. 1991 Jan;150(3):205-8
pubmed: 2044594
Mol Genet Metab. 2008 Apr;93(4):475-80
pubmed: 18164228
J Pediatr. 2020 Jan;216:9-11.e1
pubmed: 31610929
Clin Chem. 2007 Jul;53(7):1364-9
pubmed: 17510301
J Pediatr. 1992 Nov;121(5 Pt 1):710-4
pubmed: 1432418
J Pediatr. 2001 Jan;138(1):10-7
pubmed: 11148506
Ann Nutr Metab. 2020;76(4):268-276
pubmed: 32683363
Pediatr Blood Cancer. 2016 Apr;63(4):740-2
pubmed: 26806811
J Pediatr. 2008 May;152(5):731-3
pubmed: 18410783
J Inherit Metab Dis. 2008 Jun;31(3):350-60
pubmed: 18563633
J Pediatr. 2010 Jul;157(1):162-3
pubmed: 20400092
J Inherit Metab Dis. 2014 Nov;37(6):881-7
pubmed: 24970580
Br J Haematol. 2006 Jul;134(2):125-36
pubmed: 16846473
Semin Perinatol. 2015 Apr;39(3):171-87
pubmed: 25979780
Mol Genet Metab Rep. 2020 Jan 02;22:100553
pubmed: 31908952
JIMD Rep. 2014;16:65-73
pubmed: 24997714
Clin Chim Acta. 2015 Oct 23;450:342-8
pubmed: 26368264
Genes (Basel). 2020 Aug 29;11(9):
pubmed: 32872442
PLoS One. 2017 Sep 15;12(9):e0184897
pubmed: 28915261
J Inherit Metab Dis. 2007 Aug;30(4):585-92
pubmed: 17643193
J Inherit Metab Dis. 2015 Nov;38(6):1007-19
pubmed: 25762406
J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S395-404
pubmed: 18956250
Clin Biochem. 2014 Dec;47(18):312-7
pubmed: 25204964
Pediatrics. 2013 Jul;132(1):e257-61
pubmed: 23776111
Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19995-20000
pubmed: 18056804
JAMA. 2011 Mar 23;305(12):1198-200
pubmed: 21427371
Eur J Pediatr. 2004 Apr;163(4-5):196-201
pubmed: 14762712
J Pediatr Endocrinol Metab. 2020 May 26;33(5):639-645
pubmed: 32304307
Haematologica. 2005 Dec;90(12 Suppl):ECR45
pubmed: 16464760
Hum Mutat. 2009 Nov;30(11):1558-66
pubmed: 19760748
Semin Pediatr Neurol. 2016 Nov;23(4):257-272
pubmed: 28284388
Orphanet J Rare Dis. 2014 Sep 02;9:130
pubmed: 25205257

Auteurs

Sonia Pajares (S)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.
Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.

Jose Antonio Arranz (JA)

Unit of Metabolic Diseases, Hospital Vall D'Hebrón, Barcelona, Spain.

Aida Ormazabal (A)

Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Mireia Del Toro (M)

Unit of Metabolic Diseases, Hospital Vall D'Hebrón, Barcelona, Spain.

Ángeles García-Cazorla (Á)

Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Aleix Navarro-Sastre (A)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.

Rosa María López (RM)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.
Biomedical Research Institute, August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Silvia María Meavilla (SM)

Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Mariela Mercedes de Los Santos (MM)

Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Camila García-Volpe (C)

Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Jose Manuel González de Aledo-Castillo (JMG)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.

Ana Argudo (A)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.

Jose Luís Marín (JL)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.

Clara Carnicer (C)

Unit of Metabolic Diseases, Hospital Vall D'Hebrón, Barcelona, Spain.

Rafael Artuch (R)

Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Inborn Errors of Metabolism Unit, Hospital Sant Joan de Déu, Barcelona, Spain.

Frederic Tort (F)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.
Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Biomedical Research Institute, August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Laura Gort (L)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.
Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Biomedical Research Institute, August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Rosa Fernández (R)

Maternal and Child Health Service, Public Health Agency of Catalonia, Health Department, Government of Catalonia, Barcelona, Spain.

Judit García-Villoria (J)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain.
Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain.
Biomedical Research Institute, August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Antonia Ribes (A)

Sección de Errores Congénitos del Metabolismo-IBC, Servicio de Bioquímica Y Genética Molecular, Hospital Clínic de Barcelona, C/ Mejía Lequerica S/N, Edificio Helios III, 08028, Barcelona, Spain. aribes@clinic.cat.
Center for Biomedical Research Network on Rare Diseases (CIBERER), Madrid, Spain. aribes@clinic.cat.
Biomedical Research Institute, August Pi I Sunyer (IDIBAPS), Barcelona, Spain. aribes@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH